This could change how we think about treating cancer. Researchers at KAIST led by Kwang-Hyun Cho have developed a method that ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

Among childhood cancer survivors, we evaluated not previously explored relationships between colorectal subsequent malignant neoplasm (SMN) incidence and colorectum-specific radiation dose metrics ...

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

Colorectal cancer stands as the third leading cause of cancer-related deaths in US men and the fourth leading cause in US women, according to the American Cancer Society. This year, over 150,000 ...